Two beclometasone dipropionate inhalers will be discontinued at the end of November, the government has said. (The Pharmacist) - Aug 26, 2026 - "A Tier 2 medium impact medicines supply notification (MSN) has been issued by the Department of Health and Social Care (DHSC) for beclometasone dipropionate (Clenil Modulite) 50 micrograms/dose and 250 micrograms/dose inhalers...The corticosteroid beclometasone dipropionate is commonly used for the maintenance treatment of asthma in adults and children through reducing inflammation in the airways...Community Pharmacy England (CPE) said that beclometasone dipropionate (Soprobec) 50 micrograms/dose and 250 micrograms/dose inhalers remain available and can support increased demand...The Medicines and Healthcare products Regulatory Agency (MHRA) said the new lower-carbon inhalers would be available in the UK later this year."
Commercial • Asthma • Immunology
|